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The Alaska Education and Research Towards Health 
(EARTH)  Study  is  being  conducted  to  determine  the 
prevalence  of  clinically  measured  chronic  disease  risk 
factors in a large population of American Indian/Alaska 
Native  people  (AI/AN).  We  report  these  estimates  and 
compare  them  with  those  for  the  overall  US  popula-
tion, as assessed by the National Health and Nutrition 
Examination Survey (NHANES).
Methods
We measured blood pressure, height, weight, and fast-
ing serum lipids and glucose in a prospective cohort of 
3,822 AI/AN participants who resided in Alaska during 
2004 through 2006. We categorized participants as hav-
ing  chronic  disease  risk  factors  if  their  measurements 
exceeded  cutoffs  that  were  determined  on  the  basis  of 
national recommendations. We analyzed the prevalence of 
risk factors by sex and age and compared the age-adjusted 
prevalence with 1999-2004 NHANES measurements.
Results
EARTH participants were significantly more likely than 
NHANES participants to be overweight or obese and to 
have impaired fasting glucose, low high-density lipopro-
tein cholesterol, high low-density lipoprotein cholesterol, 
and hypertension. The prevalence of high total cholesterol 
and triglycerides was not significantly different between 
the 2 study populations.
Conclusion
We provide baseline clinical measurements for chronic 
disease risk factors for a larger study sample than any 
previous study of AI/AN living in Alaska. The prevalence 
of  most  risk  factors  measured  exceeded  national  rates. 
These data can be used to tailor health interventions and 
reduce health disparities.
Introduction
Alaska  Native  people  are  a  heterogeneous  population; 
more than 200 federally recognized tribes are widely dis-
persed in rural and urban areas across the state. The preva-
lence of chronic diseases is higher among tribal communities 
than  among  other  US  racial/ethnic  minority  populations, 
and the associated mortality is higher than among US non-
Hispanic whites (1,2). Alaska Native people experience lower 
mortality from diabetes and heart disease than do other US 
racial/ethnic minority populations but higher mortality from 
cerebrovascular  diseases  and  malignant  neoplasms  (2). 
Heart disease, cerebrovascular disease, chronic obstructive 
pulmonary disease, chronic liver disease, and diabetes are 
5 of the 10 leading causes of death among Alaska Native 
people (1). Additionally, the prevalence of risk factors such 
as tobacco use and obesity is higher among Alaska Native 
than non-Native Alaska residents (3).
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American Indian and Alaska Native people (AI/AN) are 
generally not included in national surveys that monitor 
health status, or the numbers are too small to draw mean-
ingful  conclusions.  Data,  when  available,  are  typically 
from telephone surveys and are self-reported. Few studies 
have collected data for AI/AN from clinical measurements, 
and those that have focused largely on a specific disease, 
age group, or geographic area (4-6). No data are available 
to indicate the prevalence of measured clinical risk fac-
tors from a large population of AI/AN. Thus, it is unclear 
whether the prevalence of selected clinical risk factors is 
the same for AI/AN as for other populations.
The  Alaska  Education  and  Research  Towards  Health 
(EARTH) Study is a prospective cohort study of predomi-
nately Alaska Native people (95% AN, 5% AI) who reside 
in the state. It is designed to examine the effects of lifestyle 
and clinical risk factors on the development of chronic dis-
eases. The objective of our analysis was to report measured 
clinical data for blood pressure, height, weight, and fasting 
serum lipids and glucose among EARTH participants and 
to compare the prevalence of elevated risk in this popula-
tion with that of all US racial/ethnic populations assessed 




We have described the methods of the EARTH Study in 
detail elsewhere (7). We recruited participants from south-
west (Yukon-Kuskokwim Delta), southeast (Panhandle), 
and southcentral (Anchorage area) Alaska. Eligibility cri-
teria included being aged 18 years or older, being AI/AN 
and  eligible  for  health  care  through  the  Indian  Health 
Service, residing in the study area, and being able to pro-
vide informed consent. Methods of recruitment included 
presentations to tribal groups and health care providers, 
informational tables staffed by study personnel at com-
munity events, house-to-house recruiting, brochures and 
flyers  in  public  locations,  and  public  service  announce-
ments on local radio and in newspapers. The Alaska Area 
Institutional  Review  Board,  the  Indian  Health  Service 
Institutional  Review  Board,  the  regional  tribal  health 
organizations,  and  the  tribal  councils  of  participating 
study communities approved the study.
We summarize data collected from 3,822 participants in 
26 Alaska communities from March 2004 through August 
2006.  We  asked  pregnant  women  and  chemotherapy 
patients  to  participate  at  a  later  date.  On  the  basis  of 
2000 AI/AN census data for each community, participa-
tion ranged from 2% to 49% of eligible adults; the median 
participation rate was 29%.
Measurement and outcomes
EARTH  participants  completed  self-administered  and 
interviewer-administered  questionnaires  on  demograph-
ics, diet, physical activity, lifestyle and cultural practic-
es, environmental exposures, cancer-screening practices, 
medical and reproductive history, and family history of 
chronic  diseases.  Computer-assisted  questionnaires  on 
touch-screen panels were used with an audio version of the 
questionnaires in English or Yupik (8). In the question-
naires, we asked participants if a health care provider had 
ever told them that they had specific chronic diseases. All 
participants were included in the analysis even if they had 
a self-reported medical history of hypertension, diabetes, 
or dyslipidemia.
We  measured  serum  lipids  and  glucose,  seated  blood 
pressure, and standing height, weight, and waist circum-
ference.  We  report  the  measurement  methods  in  detail 
elsewhere (7,9,10). We asked study participants to fast for 
9 hours before their study visit to meet requirements for 
triglyceride and glucose measurements. Only participants 
who reported fasting for 9 hours or more were measured 
for serum lipids and glucose. We gave participants who 
enrolled but had not fasted the option of completing the 
visit except for the blood test and returning at a later date 
to complete the blood test.
We based the clinical risk factor categories on recommen-
dations from the National Cholesterol Education Program, 
the American Diabetes Association, and the Joint National 
Committee  on  Prevention,  Detection,  Evaluation,  and 
Treatment  of  High  Blood  Pressure  (11-13).  Specifically, 
we  used  the  following  definitions:  hypertension  (≥140 
mm Hg systolic or ≥90 mm Hg diastolic), prehypertension 
(120-139 mm Hg systolic or 80-89 mm Hg diastolic), high 
serum cholesterol (≥200 mg/dL), high low-density lipopro-
tein (LDL) cholesterol (≥130 mg/dL), low high-density lipo-
protein (HDL) cholesterol (<40 mg/dL), high triglycerides 
(≥150 mg/dL), overweight (body mass index [BMI] 25.0-
29.9 kg/m2), obesity (BMI ≥30.0 kg/m2), extreme obesity 
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ence >102 cm for men and >88 cm for women), and high 
fasting plasma glucose (3 risk categories: 100-109 mg/dL, 
110-125 mg/dL, and >125 mg/dL).
Statistical analysis
We  computed  basic  summary  statistics  to  provide  an 
overview of the study sample compared with all AI/AN in 
Alaska (2000 US census data) (14,15). To determine the 
prevalence of the selected clinical risk factors in the study 
population, we transformed continuous data into risk cat-
egories and calculated 95% confidence intervals (CIs). We 
determined the percentage of participants who exceeded 
cutoff levels separately for men and women aged 18 to 
39 years, 40 to 59 years, and 60 years or older. Age and 
sex differences for all risk factors were calculated using 
logistic regression, and all analyses were conducted using 
SPSS  version  16  for  Windows  (IBM,  Chicago,  Illinois). 
Significance was set at P < .05.
For comparison with NHANES, only data for EARTH 
participants  aged  20  years  or  older  were  included  (n  = 
3,568). EARTH data were age-adjusted by the direct meth-
od to 2000 census data estimates using 5 age groups: 20 to 
34, 35 to 44, 45 to 54, 55 to 64, and 65 years or older (16). 
We obtained 1999-2004 NHANES data for all US racial/
ethnic groups from published sources for comparison (16-
20). In addition to testing for nonoverlapping 95% CIs, we 
used the methods described by Dever (18) for calculating 
critical values to test for difference in rates between the 
observed rate (EARTH) and a standard rate (NHANES). 
All differences that had nonoverlapping CIs were signifi-
cantly different according to the Dever method.
Results
Most  participants  were  women  (61%),  had  at  least  a 
high school education (77%), were unmarried (57%), were 
unemployed (55%), and rated their health status as good 
or better (75%) (Table 1). More than 33% of participants 
reported  speaking  either  their  native  language  only  or 
both their native language and English in the home. The 
most  common  ethnicities  reported  were  Yupik,  Cupik, 
or Inupiaq Eskimo (62%), followed by Southeast Alaska 
Indian  (Haida,  Tlingit,  Tsimshian)  (29%),  Athabaskan 
(10%),  Aleut  (9%),  and  American  Indian  (5%)  (partici-
pants could report more than 1 ethnicity). Eight percent 
of participants reported that they were of native descent, 
tribe unknown. Demographic characteristics were similar 
to those of census-generated estimates for AI/AN resid-
ing  in  Alaska,  but  EARTH  participants  reported  lower 
income, higher unemployment, and lower health status.
The most common risk factor overall among men was 
prehypertension (49%) (Table 2). For men aged 40 to 59 
years, high serum cholesterol was the most common risk 
factor (49%), and for men aged 60 years or older, abdomi-
nal obesity was the most common risk factor (57%). The 
most common risk factor among women was abdominal 
obesity (70%); this was true across all age groups but was 
highest among women aged 60 years or older.
The age-adjusted odds of hypertension, prehypertension, 
high LDL cholesterol, overweight, and the 100 to 109 mg/
dL glucose risk category were significantly higher among 
men than women (Table 3). The higher risk categories for 
blood glucose (≥110 mg/dL) were not significantly associat-
ed with sex after adjusting for age. The odds of obesity and 
extreme obesity were significantly higher among women 
than men. For most risk factors, sex-adjusted prevalence 
increased significantly with age. The rates of overweight 
and extreme obesity were not significantly associated with 
age after adjusting for sex.
The prevalence of low HDL and high LDL cholesterol was 
higher among EARTH participants than among NHANES 
participants but did not differ significantly for high total 
cholesterol  or  triglycerides  (Figure  1).  Additionally,  the 
prevalence  of  overweight,  obesity,  impaired  fasting  glu-
cose, and hypertension were significantly higher among 
EARTH participants than among NHANES participants 
(Figure  2).  The  prevalence  of  overweight  and  obesity 
among AI/AN women in the EARTH Study was particu-
larly high (78%) compared with all races/ethnicities from 
NHANES (66%).
Discussion
This study provides detailed results of selected clinical 
risk measurements from almost 4,000 AI/AN adults living 
in both rural and urban areas of Alaska. We document 
high  prevalence  of  chronic  disease  risk  factors  in  this 
population and differences between this population and 
the US overall population on the basis of NHANES data. 
The prevalence of most risk factors in the Alaska study 
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group increased with age and was more common among 
men than women, except for overweight and obesity.
The  overall  prevalence  of  hypertension  (men,  13%; 
women, 11%) was the lowest among the risk factors mea-
sured in this study. However, 28% to 49% of participants 
had  prehypertension.  The  prevalence  of  hypertension 
among EARTH participants was significantly higher than 
among NHANES participants for all races/ethnicities. The 
Strong Heart Study reported that in nondiabetic American 
Indian participants aged 45 to 74 years, prehypertension 
increased the likelihood of cardiovascular events by 80% 
compared  with  their  normotensive  counterparts  (21). 
Similar results were reported by the Framingham Heart 
Study (22).
The overall prevalence of high cholesterol among EARTH 
participants  was  40%.  The  prevalence  of  low  HDL  and 
high  LDL  cholesterol  among  EARTH  participants  was 
higher than among NHANES participants. Historically, 
Alaska  Natives  subsisted  on  wild  foods  such  as  fish 
and  marine  mammals,  which  provided  healthful  fats. 
However, most Alaska Natives are now more sedentary 
and have transitioned to a mixed traditional and Western 
diet, and the high prevalence of dyslipidemia is likely to 
continue (23,24).
The prevalence of overweight and obesity also was high 
among EARTH participants (women, 78%; men, 68%). A 
similar trend held for abdominal obesity. Although obe-
sity was virtually nonexistent in Alaska before European 
explorations  (25),  studies  of  Alaska  Natives  in  remote 
villages in the 1960s through 1980s documented a steady 
increase in the percentage of the population aged 40 years 
or  older  who  weighed  14  kg  (30  lb)  above  the  average 
for whites of the same age, height, and sex (26). These 
trends are similar to other AI/AN populations living in the   
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Figure 1. Age-adjusted prevalence of dyslipidemia for Alaska EARTH Study 
participants, 2004-2006, compared with Alaska NHANES participants, 
1999-2004. Error bars represent 95% confidence intervals. Direct age stan-
dardization is based on the 2000 census standard population for adults 
aged 20 years or older using age groups 20 to 4 years, 5 to 44 years, 
45 to 54 years, 55 to 64 years, and 65 years or older. Clinical risk factor 
categories for EARTH Study participants are based on recommendations 
from the National Cholesterol Education Program (11). Clinical risk factor 
categories for NHANES participants are based on Health, United States, 
2007 (16), Hyre et al (19), and Kuklina et al (20). Abbreviations: EARTH, 
Education and Research Towards Health; NHANES, National Health and 
Nutrition Examination Survey; LDL, low-density lipoprotein; HDL, high-density 
lipoprotein.
Figure 2. Age-adjusted prevalence of clinical risk factors for Alaska EARTH 
Study participants, 2004-2006, compared with Alaska NHANES participants, 
1999-2004. Error bars represent 95% confidence intervals. Direct age stan-
dardization is based on the 2000 census standard population for adults 
aged 20 years or older using age groups 20 to 4 years, 5 to 44 years, 
45 to 54 years, 55 to 64 years, and 65 years or older. Clinical risk factor 
categories for EARTH Study participants are based on recommendations 
from the American Diabetes Association and the Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(12,1). Clinical risk factor categories for NHANES participants are based 
on Health, United States, 2007 (16) and Cowie et al (17). Abbreviations: 
EARTH, Education and Research Towards Health; NHANES, National Health 
and Nutrition Examination Survey.contiguous United States. A review of data from the Indian 
Health Service Diabetes Care and Outcomes Audit found 
that BMI was consistently higher among women than men 
in all age groups and among younger AI/AN adults and 
that the prevalence of extreme obesity was increasing (27). 
Among EARTH participants, the prevalence of extreme 
obesity was also higher in women than men, particularly 
younger women.
Short-term  studies  indicate  that  approximately  25% 
of  people  with  impaired  fasting  glucose  (IFG)  progress 
to diabetes (28), and with longer observation, up to 70% 
appear to develop diabetes (29). NHANES age-adjusted 
data indicate the prevalence of IFG to be approximately 
26% nationally (17), whereas EARTH age-adjusted IFG 
prevalence was 37%. As found in other studies, the preva-
lence of IFG increased with age among study participants 
and was higher among men than women.
This study has several limitations. First, analysis was 
based on a convenience sample that included more women 
than men. However, when possible, we report sex-specific 
data. The age, education, and marital status of participants 
were similar to those reported in the 2000 census for AI/AN 
living in Alaska. Second, lipids and glucose were measured 
with a fingerstick blood sample using the Cholestech LDX 
(Cholestech,  Hayward,  California),  a  method  that  may 
not be directly comparable with the NHANES laboratory 
method. However, studies have shown good correlation of 
lipid values measured by the Cholestech LDX and those 
from serum obtained from venous blood samples (10,30). 
In addition, the EARTH Study adhered to quality control 
standards,  including  staff  training,  procedure  manuals, 
logs, and site visits, to assure consistent data collection. 
Finally, the EARTH Study did not assess the use of medi-
cations  for  hypertension  and  dyslipidemia,  which  may 
have influenced lipid and blood pressure values.
We have documented the high prevalence of chronic dis-
ease risk factors among AI/AN living in Alaska and noted 
differences  compared  with  the  general  US  population. 
Measurements for a substantial proportion of study par-
ticipants were outside of normal ranges but below the cut-
off for clinical diagnosis. Studies are needed to determine 
the effect of these risk factors on chronic disease incidence 
in AI/AN populations. These data can be used to prioritize 
health  promotion  and  disease  prevention  activities  at 
the local and regional levels to reduce health disparities 
among Alaska Native populations.
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Tables
Table 1. Characteristics of AI/AN Alaska Residents Who Participated in the EARTH Study, 2004-2006, Compared With AI/AN 
Alaska Residents Overall, US Census, 2000
Characteristic
EARTH Study, No. (%) 
N = 3,822
Censusa, No. (%) 
N = 119,331
Regionb
Southcentral 1,94 (7) 6,428 (51)
Southeast 887 (2) 15,079 (21)
Southwest 1,541 (40) 20,226 (28)
Age, yc
18-9 1,874 (49) 7,25 (52)
40-59 1,517 (40) 24,816 (5)
≥60 41 (11) 8,91 (1)
Sexc
Men 1,502 (9) 60,212 (51)
Women 2,20 (61) 59,119 (49)
Marital statusd
Married or living as married 1,60 (4) 0,705 (9)
Separated, divorced, or never married 2,177 (57) 48,118 (61)
Educationc
High school diploma or more 2,9 (77) 4,469 (74)
Employment statuse
Employed or self-employed 1,717 (45) 45,74 (60)
 
Abbreviations: AI/AN, American Indian/Alaska Native people; EARTH, Education and Research Towards Health; NA, not assessed. 
a Census 2000 data for Alaska (14). Totals do not equal 119,1 for all categories because of missing responses. 
b Census 2000 data for the corresponding Alaska Native Regional Corporations [ANRC]) Southcentral: Cook Inlet ANRC; Southeast: Sealaska ANRC; Southwest: 
Calista ANRC (14). 
c Census 2000 data for population aged 18 years or older (14). 
d Census 2000 data for population aged 15 years or older (14). 
e Census 2000 data for population aged 16 years or older (14). 
f Census 2000 data for households. EARTH data were missing 555 responses for this variable (14). 
g Census 2000 data for population aged 5 years or older (14). 
h Behavioral Risk Factor Surveillance System 2005, Alaska, all races/ethnicities (15). 
i Percentages do not total 100 because participants could choose more than 1 ethnicity.
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Characteristic
EARTH Study, No. (%) 
N = 3,822
Censusa, No. (%) 
N = 119,331
Annual household income, $f
≤15,000 1,4 (41) 6,56 (20)
15,001-25,000 526 (16) 5,178 (16)
25,001-5,000 446 (14) 4,40 (14)
5,001-50,000 444 (14) 5,074 (16)
>50,000 505 (15) 10,904 (4)
Language spoken at homeg
Non-English or both 1,262 () 1,10 (29)
English only 2,542 (67) 76,45 (71)
Self-reported health statush
Excellent, very good, or good 2,864 (75) 2,40 (87)
Fair or poor 952 (25) 400 (1)
Ethnicityi
Eskimo 2,57 (62) NA
Southeast Alaska Indian 1,089 (29) NA
Athabaskan 90 (10) NA
Aleut 2 (9) NA
American Indian 205 (5) NA
Other Native (tribe unknown) 285 (8) NA
 
Abbreviations: AI/AN, American Indian/Alaska Native people; EARTH, Education and Research Towards Health; NA, not assessed. 
a Census 2000 data for Alaska (14). Totals do not equal 119,1 for all categories because of missing responses. 
b Census 2000 data for the corresponding Alaska Native Regional Corporations [ANRC]) Southcentral: Cook Inlet ANRC; Southeast: Sealaska ANRC; Southwest: 
Calista ANRC (14). 
c Census 2000 data for population aged 18 years or older (14). 
d Census 2000 data for population aged 15 years or older (14). 
e Census 2000 data for population aged 16 years or older (14). 
f Census 2000 data for households. EARTH data were missing 555 responses for this variable (14). 
g Census 2000 data for population aged 5 years or older (14). 
h Behavioral Risk Factor Surveillance System 2005, Alaska, all races/ethnicities (15). 
i Percentages do not total 100 because participants could choose more than 1 ethnicity.
Table 1. (continued) Characteristics of AI/AN Alaska Residents Who Participated in the EARTH Study, 2004-2006, Compared 
With AI/AN Alaska Residents Overall, US Census, 2000Table 2. Prevalence of Clinical Risk Factors for Chronic Disease, by Age and Sex, Among Alaska Native and American Indian 
People, EARTH Study, Alaska, 2004-2006
Risk Factora
Men, % (95% CI)
Age 18-39 y 
n = 742
Age 40-59 y 
n = 610




Hypertension 10 (8-12) 14 (11-16) 22 (15-29) 1 (8-17)
Prehypertension 55 (52-59) 45 (41-49) 8 (1-46) 49 (46-5)
High total cholesterol 1 (28-5) 49 (45-5) 48 (40-56) 40 (6-44)
High LDL cholesterol 27 (24-1) 7 (-41) 7 (28-45) 2 (27-6)
Low HDL cholesterol 27 (24-1) 20 (17-2) 24 (17-0) 24 (19-28)
High triglycerides 25 (22-28) 29 (26-) 29 (21-6) 27 (22-1)
Abdominal obesity 28 (25-1) 41 (7-45) 57 (49-65) 6 (2-40)
BMI, kg/m2 b 
25.0-29.9 4 (1-7) 8 (4-41) 6 (28-44) 6 (2-40)
≥30.0 29 (25-2)  (29-7) 4 (5-51) 2 (28-6)
≥40.0 5 (4-7) 6 (4-7) 6 (2-10) 6 (1-10)
Fasting glucose, mg/dL
100-109 26 (2-0) 1 (27-4) 26 (19-) 28 (24-2)
110-125 7 (6-9) 1 (11-16) 21 (15-28) 11 (6-16)
>125  (2-5) 7 (5-9) 1 (7-18) 6 (1-11)
Risk Factora
Women, % (95% CI)
Age 18-39 y 
n = 1,132
Age 40-59 y 
n = 907




Hypertension  5 (-6) 1 (11-16) 29 (24-4) 11 (7-15)
Prehypertension 22 (19-24) 2 (29-5) 40 (4-45) 28 (24-1)
High total cholesterol 26 (2-29) 51 (48-55) 6 (57-69) 40 (7-44)
High LDL cholesterol 14 (12-16) 28 (25-1) 9 (-45) 22 (19-26)
Low HDL cholesterol 1 (11-15) 7 (5-9) 11 (7-14) 11 (7-14)
High triglycerides 25 (2-28) 2 (29-5) 4 (28-9) 29 (26-2)
Abdominal obesity 65 (62-68) 74 (71-77) 80 (75-84) 70 (68-72)
BMI, kg/m2 b
25.0-29.9 29 (26-1) 0 (27-) 1 (26-7) 29 (26-)
≥30.0 47 (44-50) 51 (48-54) 52 (46-58) 49 (46-52)
≥40.0 11 (9-1) 11 (9-1) 8 (4-11) 11 (7-14)
Fasting glucose, mg/dL 
100-109 19 (17-22) 22 (19-25) 28 (2-4) 21 (18-25)
110-125 6 (4-7) 1 (11-15) 18 (1-22) 10 (6-14)
>125  (2-4) 7 (5-8) 7 (4-10) 5 (1-9)
 
Abbreviations: EARTH, Education and Research Towards Health; CI, confidence interval; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI, body 
mass index. 
a Clinical risk factor categories based on recommendations from the National Cholesterol Education Program, the American Diabetes Association, and the Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (11-1). 
b BMI categories are not mutually exclusive. All of the participants who appear in the ≥40 category also appear in the ≥30 category.
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Table 3. Odds of Clinical Risk Factors for Chronic Disease, by Age and Sex, Among Alaska Native and American Indian 
People, EARTH Study, Alaska, 2004-2006
Risk Factora ORb for 1-Year Increase in Age (95% CI) ORc for Men Compared With Women (95% CI)
Hypertension 1.0 (1.0-1.04) 1.66 (1.4-1.94)
Prehypertension 1.01 (1.01-1.02) 2.45 (2.12-2.85)
High total cholesterol 1.04 (1.0-1.04) 1.04 (0.91-1.20)
High LDL cholesterol 1.0 (1.02-1.0) 1.71 (1.46-2.01)
Low HDL cholesterol 0.99 (0.98-0.99) 0.68 (0.59-0.80)
High triglycerides 1.01 (1.01-1.02) 0.98 (0.84-1.15)
Abdominal obesity 1.0 (1.02-1.0) 0.24 (0.21-0.27)
BMI, kg/m2 d
25.0-29.9 1.00 (1.00-1.00) 1.2 (1.15-1.52)
≥30.0 1.01 (1.01-1.02) 0.50 (0.4-0.57)
≥40.0 1.00 (1.00-1.00) 0.50 (0.9-0.65)
Fasting glucose, mg/dL
100-109 1.01 (1.01-1.02) 1.46 (1.25-1.71)
110-125 1.0 (1.0-1.04) 1.20 (0.96-1.50)
>125 1.0 (1.02-1.04) 1.27 (0.94-1.71)
 
Abbreviations: EARTH, Education and Research Towards Health; OR, odds ratio; CI, confidence interval; LDL, low-density lipoprotein; HDL, high-density lipopro-
tein; BMI, body mass index. 
a Clinical risk factor categories based on recommendations from the National Cholesterol Education Program, the American Diabetes Association, and the Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (11-1). 
b Adjusted for sex. All values except those for BMI 25.0-29.9 and BMI ≥40.0 were significant at P < .001 (χ2 test). 
c Adjusted for age. All values except those for high total cholesterol, high triglycerides, fasting glucose 110-125 mg/dL, and fasting glucose >125 mg/dL were 
significant at P < .001 (χ2 test ). 
d BMI categories are not mutually exclusive. All of the participants who appear in the ≥40 category also appear in the ≥30 category.